Please contact us for more information or to learn if you are eligible to participate.
The purpose of this study is to evaluate the efficacy and safety of mirikizumab as maintenance therapy in participants who completed prior 12-week induction study AMAN.
Sriramanchandra M. Badiga, MD
Eli Lilly and Company/USA
Type of Trial